Segment Information |
16. Segment Information
The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and its chief operating decision makers, being the President and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property Licensing and Consumer Products. Licensing revenues are significantly concentrated on one licensee.
|
|
IP Licensing |
|
|
Consumer Products |
|
|
Corporate |
|
|
Consolidated Total |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
External revenue |
|
|
69,750 |
|
|
|
99,631 |
|
|
|
— |
|
|
|
169,381 |
|
CoGS |
|
|
— |
|
|
|
(65,959 |
) |
|
|
— |
|
|
|
(65,959 |
) |
Operating expenses |
|
|
(300,034 |
) |
|
|
(293,487 |
) |
|
|
(1,432,156 |
) |
|
|
(2,025,677 |
) |
Segment loss |
|
|
(230,284 |
) |
|
|
(259,815 |
) |
|
|
(1,432,156 |
) |
|
|
(1,922,255 |
) |
Total assets |
|
|
694,684 |
|
|
|
124,412 |
|
|
|
1,167,130 |
|
|
|
1,986,226 |
|
|
17. |
Segment Information |
|
|
|
The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and its chief operating decision makers, being the president and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The company has identified two reportable segments: Intellectual Property Licensing and Consumer Products. Licensing revenues are significantly concentrated on three licensees. |
|
|
IP
Licensing
|
|
|
Consumer
Products
|
|
|
Corporate |
|
|
Consolidated
Total
|
|
External Revenue |
|
$ |
198,000 |
|
|
$ |
24,610 |
|
|
$ |
— |
|
|
$ |
222,610 |
|
CoGS |
|
$ |
— |
|
|
$ |
(22,893 |
) |
|
$ |
— |
|
|
$ |
(22,893 |
) |
Operating Expenses |
|
$ |
(1,211,733 |
) |
|
$ |
(968,947 |
) |
|
$ |
(2,177,450 |
) |
|
$ |
(4,358,130 |
) |
Segment Loss |
|
$ |
(1,013,733 |
) |
|
$ |
(967,230 |
) |
|
$ |
(2,177,450 |
) |
|
$ |
(4,158,413 |
) |
Total Assets |
|
$ |
645,969 |
|
|
$ |
127,396 |
|
|
$ |
1,901,854 |
|
|
$ |
2,675,219 |
|
|